BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 18591981)

  • 41. Macrocycles and macrocyclization in anticancer drug discovery: Important pieces of the puzzle.
    Zhang C; Liu F; Zhang Y; Song C
    Eur J Med Chem; 2024 Mar; 268():116234. PubMed ID: 38401189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lead discovery and optimization strategies for peptide macrocycles.
    Bhat A; Roberts LR; Dwyer JJ
    Eur J Med Chem; 2015 Apr; 94():471-9. PubMed ID: 25109255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery.
    Marsault E; Peterson ML
    J Med Chem; 2011 Apr; 54(7):1961-2004. PubMed ID: 21381769
    [No Abstract]   [Full Text] [Related]  

  • 44. Structural and conformational determinants of macrocycle cell permeability.
    Over B; Matsson P; Tyrchan C; Artursson P; Doak BC; Foley MA; Hilgendorf C; Johnston SE; Lee MD; Lewis RJ; McCarren P; Muncipinto G; Norinder U; Perry MW; Duvall JR; Kihlberg J
    Nat Chem Biol; 2016 Dec; 12(12):1065-1074. PubMed ID: 27748751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pyrrolidinyl-spirooxindole natural products as inspirations for the development of potential therapeutic agents.
    Galliford CV; Scheidt KA
    Angew Chem Int Ed Engl; 2007; 46(46):8748-58. PubMed ID: 17943924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural products as a robust source of new drugs and drug leads: past successes and present day issues.
    Rishton GM
    Am J Cardiol; 2008 May; 101(10A):43D-49D. PubMed ID: 18474274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthetic analogs of natural glycosides in drug discovery and development.
    Grynkiewicz G; Szeja W; Boryski J
    Acta Pol Pharm; 2008; 65(6):655-76. PubMed ID: 19172847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macrocyclizations for medicinal chemistry: synthesis of druglike macrocycles by high-concentration Ullmann coupling.
    Collins JC; Farley KA; Limberakis C; Liras S; Price D; James K
    J Org Chem; 2012 Dec; 77(24):11079-90. PubMed ID: 23167628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties?
    Giordanetto F; Kihlberg J
    J Med Chem; 2014 Jan; 57(2):278-95. PubMed ID: 24044773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physicochemical and biological characterization of novel macrocycles derived from o-phthalaldehyde.
    Reddy PM; Ho YP; Shanker K; Rohini R; Ravinder V
    Eur J Med Chem; 2009 Jun; 44(6):2621-5. PubMed ID: 18996622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring the synthetic approaches and clinical prowess of established macrocyclic pharmaceuticals.
    Sun JG; Nie P; Herdewijn P; Li XJ
    Eur J Med Chem; 2024 Jan; 264():116051. PubMed ID: 38104377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combining two-directional synthesis and tandem reactions. Part 21: Exploitation of a dimeric macrocycle for chain terminus differentiation and synthesis of an sp(3)-rich library.
    Storr TE; Cully SJ; Rawling MJ; Lewis W; Hamza D; Jones G; Stockman RA
    Bioorg Med Chem; 2015 Jun; 23(11):2621-8. PubMed ID: 25638497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthetic Opportunities and Challenges for Macrocyclic Kinase Inhibitors.
    Amrhein JA; Knapp S; Hanke T
    J Med Chem; 2021 Jun; 64(12):7991-8009. PubMed ID: 34076436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Horses for courses: reaching outside drug-like chemical space for inhibitors of challenging drug targets.
    Whitty A; Zhou L
    Future Med Chem; 2015; 7(9):1093-5. PubMed ID: 26132520
    [No Abstract]   [Full Text] [Related]  

  • 55. Synthetic studies of heterocyclic natural products.
    JoulliƩ MM; Berritt S; Forbeck EM
    Curr Opin Drug Discov Devel; 2008 Nov; 11(6):829-52. PubMed ID: 18946847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acid promoted cinnamyl ion mobility within peptide derived macrocycles.
    Zhao H; Negash L; Wei Q; LaCour TG; Estill SJ; Capota E; Pieper AA; Harran PG
    J Am Chem Soc; 2008 Oct; 130(42):13864-6. PubMed ID: 18811162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The emerging role of computational design in peptide macrocycle drug discovery.
    Mulligan VK
    Expert Opin Drug Discov; 2020 Jul; 15(7):833-852. PubMed ID: 32345066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Macrocycles as protein-protein interaction inhibitors.
    Dougherty PG; Qian Z; Pei D
    Biochem J; 2017 Mar; 474(7):1109-1125. PubMed ID: 28298556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dihedral Angle-Based Sampling of Natural Product Polyketide Conformations: Application to Permeability Prediction.
    Wang Q; Sciabola S; Barreiro G; Hou X; Bai G; Shapiro MJ; Koehn F; Villalobos A; Jacobson MP
    J Chem Inf Model; 2016 Nov; 56(11):2194-2206. PubMed ID: 27731994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enantiospecific total syntheses of kapakahines B and F.
    Newhouse T; Lewis CA; Baran PS
    J Am Chem Soc; 2009 May; 131(18):6360-1. PubMed ID: 19374357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.